Bulletin
Investor Alert

London Markets Open in:

bioMerieux S.A.

PAR: FR:BIM

GO

BIM
/zigman2/quotes/206867731/delayed

134.10

Change

+1.20 +0.90%

Volume

Volume 102,131

Jul 8, 2020, 5:35 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206867731/delayed

Previous close

132.90

134.10

Change

+1.20 +0.90%

Day low

Day high

€132.20

€134.10

Open
Open: 132.90

52 week low

52 week high

€67.45

€138.00

Open

Market cap

€15.72B

Average volume

144,916

P/E ratio

58.36

Rev. per Employee

€658,141

EPS

2.30

Dividend

0.19

Div yield

0.14%

Ex dividend date

7/14/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/fr/bim

MarketWatch News on BIM

  1. BioMerieux shares slide 10% after 2017 results

    4:06 a.m. Feb. 28, 2018

    - Carla Mozee

/news/nonmarketwatch/company/fr/bim

Other News on BIM

  1. Inside Moderna: The Covid Vaccine Front-Runner With No Track Record and an Unsparing CEO

    10:31 a.m. July 3, 2020

    - The Wall Street Journal Interactive Edition

  2. The Race to Develop Tests to Spot Coronavirus-Linked Illness

    2:09 p.m. March 3, 2020

    - The Wall Street Journal Interactive Edition

  3. At the Doctor’s Office, Expect Better, More Reliable Flu Tests

    9:13 a.m. Feb. 26, 2018

    - The Wall Street Journal Interactive Edition

/news/pressrelease/company/fr/bim

Press Releases on BIM

  1. Coronavirus Impact on Microbiology Culture Market

    6:12 a.m. May 27, 2020

    - Heraldkeepers

  2. Biochips Market Analysis as per the Latest Coronavirus Impact

    5:15 a.m. May 27, 2020

    - Heraldkeepers

  3. COVID-19 Impact on Sterilization Market

    7:27 a.m. May 26, 2020

    - Heraldkeepers

  4. Biochips Market Analysis as per the Latest Coronavirus Impact

    12:06 p.m. May 22, 2020

    - Heraldkeepers

  5. Coronavirus Impact on Transplant Diagnostics Market

    10:17 a.m. May 20, 2020

    - Heraldkeepers

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.